Purpose: : MaQaid® (Wakamoto Pharmaceutical, Tokyo, Japan, MaQ) is new Triamcinolone Acetonide (TA) commecialized in Japan for the aim to visualize posterior hyaloid during vitrectomy. Compared to other TA, like Kenalog®, its strong advantage is the point that preservative free.

Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man.

“MaQaid OPHTHALMIC INJECTION 40mg” is a prescription medicine (Rx) in Japan.

MaQaid HEXACETONIDE is indicated for intraarticular, intrasynovial or periarticular use in adults and adolescents for the symptomatic treatment of subacute and chronic inflammatory joint diseases including: - Rheumatoid arthritis. - Juvenile Idiopathic Arthritis (JIA) - Osteoarthritis and post-traumatic arthritis.

Jan 17, 2018 · To investigate whether intravitreal injection of triamcinolone acetonide (IVTA) combined with vitrectomy prevents postoperative inflammation in patients with vitreous haemorrhage (VH) due to proliferative diabetic retinopathy (PDR).

MaQaid (MaQ) is a new triamcinolone acetonide commercialised in Japan to visualize the vitreous. Because MaQ is preservative-free, it has a lower risk of ocular toxicities. However, since MaQ is only available as a powder, it needs suspenssion.

Alternative Names: MAQ-100; MaQaid; WP-0508ST Latest Information Update: 04 Oct 2023

Intravitreal preservative-free triamcinolone (Maqaid®) could be considered as a treatment option for refractory macular edema associated with RVO. Key Words: Intraocular pressure;Intravitreal injection;Macular edema;Preservative-free triamcinolone;Retinal vein occlusion

Brand name:MaQaid OPHTHALMIC INJECTION 40mg [macular edema complicated with retinal vein occlusion and noninfectious uveitis] Active ingredient:Triamcinolone acetonide Dosage form:injection Imprint or print on wrapping: Effects of this medicine

Jul 20, 2017 · The newer form of MaQaid® had a particle distribution like that of Kenacort-A®, so it should provide good visibility. Moreover, it is free of preservatives, so it may prove to be a useful aid to visualize the vitreous during vitreous surgery.